You are here
Wim van den Brink
Academic Medical Center, University of Amsterdam, and Amsterdam Institute for Addiction Research, Netherlands
Wim van den Brink received his medical degree from the VU University, Amsterdam, the Netherlands, in 1981. He trained in psychiatric epidemiology at Columbia University, New York, USA, from 1986 to 1987. In 1989, he received his PhD degree cum laude from the University of Groningen, the Netherlands, under the supervision of Professor Robert Giel. He is currently Professor of Psychiatry and Addiction at the Academic Medical Center of the University of Amsterdam, a position he has held since 1992.
The aim of Professor van den Brink’s research is to uncover the neurobiological processes involved in the development of addictive behaviours and the effects of neurobiological interventions in preventing relapse in alcohol- and drug-dependent patients and pathological gamblers, using neuropsychological tests, neurophysiological procedures, and/or neuroimaging techniques. He chaired the working groups that developed multidisciplinary guidelines for the treatment of alcohol dependence (in 2009) and opioid dependence (in 2013) in the Netherlands.
Professor van den Brink co-founded the European Association of Substance Abuse Research and was President of this Association (EASAR) from 1995 to 2010. He is President of the International Collaboration of ADHD and Substance Abuse (ICASA), and Chair of the Scientific Program Committee of the European College of Neuropsychopharmacology (ECNP) since 2005. He has authored or co-authored more than 450 peer-reviewed scientific publications and has supervised 56 PhD students. He is also editor of European Addiction Research, and was an associate editor of Drug and Alcohol Dependence until 2013, as well as serving on the editorial board of Addiction, Addiction Biology, Current Drug Abuse Reviews, the International Journal of Methods in Psychiatric Research, Mind and Brain, and the German journal Sucht. He has received a number of awards, including the Marie Curie Award for neuroimaging of the neurotoxicity of ecstasy in 2005 and the Lifetime Scientific Achievement Award from the Netherlands Psychiatric Association in 2014.